✦ LIBER ✦

Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis

✍ Scribed by Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Zan Shen; Yang Yao

Book ID: 113043134
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 366 KB
Volume: 138
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-012-1155-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis of docetaxel-based doublet

Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer

✍ Wei-Xiang Qi; Zan Shen; Yang Yao 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 382 KB

Doublet Versus Single Cytotoxic Agent as

Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

✍ Qi, Wei-Xiang; Tang, Li-na; He, Ai-na; Shen, Zan; Lin, Feng; Yao, Yang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 465 KB

Pemetrexed Versus Pemetrexed and Carbopl

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

✍ Ardizzoni, A.; Tiseo, M.; Boni, L.; Vincent, A. D.; Passalacqua, R.; Buti, S.; A 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 200 KB

The safety and efficacy of gefitinib ver

The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: A meta-analysis

✍ Chang, Chia-Hsuin; Chen, Kuan-Yu; Young-Xu, Yinong; Kurth, Tobias; Orav, E. John 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 362 KB

An economic analysis of erlotinib, docet

An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer

✍ A. Araújo; B. Parente; R. Sotto-Mayor; E. Teixeira; T. Almodôvar; F. Barata; H. 📂 Article 📅 2008 🏛 Elsevier ⚖ 288 KB

A Randomized Phase II Study of Pemetrexe

A Randomized Phase II Study of Pemetrexed or RAD001 as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients: Treatment Rationale and Protocol Dynamics

✍ Cesare Gridelli; Antonio Rossi; Floriana Morgillo; Maria Anna Bareschino; Paolo 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 104 KB